Pieter M. Pretorius

Pieter M. Pretorius

Auto-generated profile, based on publicly available information

Pieter M. Pretorius

University of Oxford, Oxford United Kingdom

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Clinical Radiology
Verified
Journal Article
Closed access
JDJ.J. Downer
J.J. Downer
PPP.M. Pretorius
P.M. Pretorius

1 March 2020 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
MLMichael C.H. Li
Michael C.H. Li
MSMkael Symmonds
Mkael Symmonds
PPPieter M. Pretorius
Pieter M. Pretorius
FSFintan Sheerin
Fintan Sheerin
KNKannan Nithi
Kannan Nithi
Arjune SenArjune Sen
Arjune Sen

1 September 2022 in medRxiv
Verified
Preprint
Open access
PDF file
LGLudovica Griffanti
Ludovica Griffanti
GGGrace Gillis
Grace Gillis
MOM. Clare O’donoghue
M. Clare O’donoghue
JBJasmine Blane
Jasmine Blane
PPPieter M. Pretorius
Pieter M. Pretorius
CMClare E. Mackay
Clare E. Mackay
The Oxford Brain Health Clinic (BHC) is a joint clinical-research service that provides memory clinic patients and clinicians access to high-quality assessments not routinely available, including brain MRI aligned with the UK Biobank imaging study (UKB). In this work we present how we 1) adapted the UKB MRI acquisition protocol to be suitable for memory clinic patients, 2) modified the imaging analysis pipeline to extract measures that are in line with radiology reports and 3) compared measures from BHC patients to the largest brain MRI study in the world (ultimately 100,000 participants). Adaptations of the UKB acquisition protocol for BHC patients include dividing the scan into core and optional sequences (i.e., additional imaging modalities) to improve patients’ tolerance for the MRI assessment. We adapted the UKB structural MRI analysis pipeline to take into account the characteristics of a memory clinic population (e.g., high amount of white matter hyperintensities and hippocampal atrophy). We then compared the imaging derived phenotypes (IDPs) extracted from the structural scans to visual ratings from radiology reports, non-imaging factors (age, cognition) and to reference distributions derived from UKB data. Of the first 108 BHC attendees (August 2020-November 2021), 92.5% completed the clinical scans, 88.0% consented to use of data for research, and 48.1% completed at least one additional research sequence, demonstrating that the protocol is well tolerated. The high rates of consent to research makes this a unique real-world quality research dataset routinely captured in a clinical service. Modified tissue-type segmentation with lesion masking greatly improved grey matter volume estimation. CSF-masking marginally improved hippocampal segmentation. The IDPs were in line with radiology reports and showed significant associations with age and cognitive performance, in line with the literature. Due to the age difference between memory clinic patients of the BHC (age range 65-101 years, average 78.3 years) and UKB participants (44-82 years, average 64 years), additional scans on elderly healthy controls are needed to improve reference distributions. Current and future work aims to integrate automated quantitative measures in the radiology reports and evaluate their clinical utility.

4 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
GGGrace Gillis
Grace Gillis
GBGaurav Bhalerao
Gaurav Bhalerao
JBJasmine Blane
Jasmine Blane
RMRobert Mitchell
Robert Mitchell
PPPieter M Pretorius
Pieter M Pretorius
LGLudovica Griffanti
Ludovica Griffanti
Introduction The analysis tools and statistical methods used in large neuroimaging research studies differ from those applied in clinical contexts, making it unclear whether these techniques can be translated to a memory clinic setting. The Oxford Brain Health Clinic (OBHC) was established in 2020 to bridge this gap between research studies and memory clinics. Methods We optimised the UK Biobank imaging framework for the memory clinic setting by integrating enhanced quality control (QC) processes (MRIQC, QUAD, and DSE decomposition) and supplementary dementia-informed analyses (lobar volumes, NBM volumes, WMH classification, PSMD, cortical diffusion MRI metrics, and tract volumes) into the analysis pipeline. We explored associations between resultant imaging-derived phenotypes (IDPs) and clinical phenotypes in the OBHC patient population (N=213), applying hierarchical FDR correction to account for multiple testing. Results 14-24% of scans were flagged by automated QC tools, but upon visual inspection, only 0-2.4% of outputs were excluded. The pipeline successfully generated 5683 IDPs aligned with UK Biobank and 110 IDPs targeted towards dementia-related changes. We replicated established associations and found novel associations between brain metrics and age, cognition, and dementia-related diagnoses. Conclusion The imaging protocol is feasible, acceptable, and yields high-quality data that is usable for both clinical and research purposes. We validated the use of this methodology in a real-world memory clinic population, which demonstrates the potential of this enhanced pipeline to bridge the gap between big data studies and clinical settings. Key Points The imaging methods, analysis techniques, and population characteristics in research studies often differ to those in traditional clinical settings. To bridge this gap, we optimised the UK Biobank imaging framework for memory clinic use by integrating enhanced quality control (QC) and supplementary analyses targeted towards dementia-related changes. We generated 5683 imaging-derived phenotypes (IDPs) aligned with UK Biobank and 110 supplementary dementia-informed IDPs that captured both established and novel associations between brain metrics and dementia-related clinical phenotypes, highlighting the value of integrating UK Biobank-aligned imaging and analyses in a real-world memory clinic population.

24 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
LGLudovica Griffanti
Ludovica Griffanti
MDMohamed Dembele
Mohamed Dembele
GGGrace Gillis
Grace Gillis
RMRobert Mitchell
Robert Mitchell
PPPieter M Pretorius
Pieter M Pretorius
CMClare Mackay
Clare Mackay
Background: With the advent of disease modifying treatments for dementia, it is essential to restructure memory clinic services to provide accurate and early diagnosis to enable precision therapies and recruitment to clinical trials. The Oxford Brain Health Clinic (BHC) offers a comprehensive clinical and embedded research assessment in the patient pathway, including a research‐quality brain MRI scan (using the UK Biobank protocol), well‐tolerated by patients (Griffanti et al., 2022, Neuroimage:Clinical). In this study we investigated whether the images obtained from BHC patients were of sufficient quality for clinical/diagnostic purposes (i.e. to provide a radiology report) and research purposes (i.e. suitable to extract quantitative measures with automated software) and whether the scan quality was related to patients’ characteristics (capacity, frailty, anxiety, cognitive impairment ‐ CI), to inform future triage to Brain Health Clinics.Method: T1 and FLAIR scans from 138 BHC patients were reported by a radiologist and independently rated as high, medium or low quality for research purposes (consensus between 2 raters). The following patients’ characteristics were evaluated: capacity (yes/no), Rockwood Clinical Frailty Scale (more frail if 5 or more), anxiety before/during the scan (low/not‐low), Addenbrooke’s Cognitive Examination III (ACE‐III, score above or below 82). A two‐sided Fisher‐Freeman‐Halton test was run to test the association between scan quality (3 classes) and patients characteristics (2 classes for each independent variable). Bonferroni‐adjusted post‐hoc comparisons were performed between scan quality classes using 2×2 Fisher’s Exact Tests.Result: The radiologist was able to provide a clinical report for all scans. Over 90% of scans were rated high or medium quality for research purposes (Fig.1). No significant associations were observed between patients’ characteristics and FLAIR quality. T1 quality was significantly associated with patients’ capacity (p = 0.001, more low‐quality images from patients lacking capacity, Fig.2) and frailty (p = 0.014, more low‐quality images from frailer patients, Fig.3).Conclusion: Research‐quality MRI scans in memory clinic are useful for both clinical and research purposes. For research comprised of high‐quality MRI, relatively generous thresholds relating to frailty and capacity could be considered to balance the trade‐off between inclusivity (i.e. increasing representativeness) and adherence to protocols.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
LGLudovica Griffanti
Ludovica Griffanti
MDMohamed Dembele
Mohamed Dembele
GGGrace Gillis
Grace Gillis
RMRobert Mitchell
Robert Mitchell
PPPieter M Pretorius
Pieter M Pretorius
CMClare Mackay
Clare Mackay
Background: With the advent of disease modifying treatments for dementia, it is essential to restructure memory clinic services to provide accurate and early diagnosis to enable precision therapies and recruitment to clinical trials. The Oxford Brain Health Clinic (BHC) offers a comprehensive clinical and embedded research assessment in the patient pathway, including a research‐quality brain MRI scan (using the UK Biobank protocol), well‐tolerated by patients (Griffanti et al., 2022, Neuroimage:Clinical). In this study we investigated whether the images obtained from BHC patients were of sufficient quality for clinical/diagnostic purposes (i.e. to provide a radiology report) and research purposes (i.e. suitable to extract quantitative measures with automated software) and whether the scan quality was related to patients’ characteristics (capacity, frailty, anxiety, cognitive impairment ‐ CI), to inform future triage to Brain Health Clinics.Method: T1 and FLAIR scans from 138 BHC patients were reported by a radiologist and independently rated as high, medium or low quality for research purposes (consensus between 2 raters). The following patients’ characteristics were evaluated: capacity (yes/no), Rockwood Clinical Frailty Scale (more frail if 5 or more), anxiety before/during the scan (low/not‐low), Addenbrooke’s Cognitive Examination III (ACE‐III, score above or below 82). A two‐sided Fisher‐Freeman‐Halton test was run to test the association between scan quality (3 classes) and patients characteristics (2 classes for each independent variable). Bonferroni‐adjusted post‐hoc comparisons were performed between scan quality classes using 2×2 Fisher’s Exact Tests.Result: The radiologist was able to provide a clinical report for all scans. Over 90% of scans were rated high or medium quality for research purposes (Fig.1). No significant associations were observed between patients’ characteristics and FLAIR quality. T1 quality was significantly associated with patients’ capacity (p = 0.001, more low‐quality images from patients lacking capacity, Fig.2) and frailty (p = 0.014, more low‐quality images from frailer patients, Fig.3).Conclusion: Research‐quality MRI scans in memory clinic are useful for both clinical and research purposes. For research comprised of high‐quality MRI, relatively generous thresholds relating to frailty and capacity could be considered to balance the trade‐off between inclusivity (i.e. increasing representativeness) and adherence to protocols.